Teva Pharmaceuticals
TEVA
TEVA
521 hedge funds and large institutions have $10.5B invested in Teva Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 53 funds opening new positions, 161 increasing their positions, 182 reducing their positions, and 79 closing their positions.
New
Increased
Maintained
Reduced
Closed
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
12% less repeat investments, than reductions
Existing positions increased: 161 | Existing positions reduced: 182
24% less funds holding in top 10
Funds holding in top 10: 17 → 13 (-4)
33% less first-time investments, than exits
New positions opened: 53 | Existing positions closed: 79
Holders
521
Holding in Top 10
13
Calls
$303M
Puts
$338M
Top Buyers
| 1 | +$210M | |
| 2 | +$97.8M | |
| 3 | +$64M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$57M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$54.9M |
Top Sellers
| 1 | -$285M | |
| 2 | -$102M | |
| 3 | -$81.3M | |
| 4 |
OAG
Orbis Allan Gray
Hamilton,
Bermuda
|
-$76.2M |
| 5 |
Renaissance Technologies
New York
|
-$67.7M |